Aadi Bioscience AADI Stock
Aadi Bioscience Price Chart
Aadi Bioscience AADI Financial and Trading Overview
| Aadi Bioscience stock price | 1.96 USD |
| Previous Close | 8.14 USD |
| Open | 8.12 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 8.07 - 8.32 USD |
| 52 Week Range | 6.8 - 14.77 USD |
| Volume | 56.67K USD |
| Avg. Volume | 115.18K USD |
| Market Cap | 200.38M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.44 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 35.25 USD |
AADI Valuation Measures
| Enterprise Value | 50.78M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.02583 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.672316 |
| Price/Book (mrq) | 1.3726146 |
| Enterprise Value/Revenue | 2.704 |
| Enterprise Value/EBITDA | -0.82 |
Trading Information
Aadi Bioscience Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -39.92% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.77 USD |
| 52 Week Low | 6.8 USD |
| 50-Day Moving Average | 7.84 USD |
| 200-Day Moving Average | 10.95 USD |
AADI Share Statistics
| Avg. Volume (3 month) | 115.18K USD |
| Avg. Daily Volume (10-Days) | 77.06K USD |
| Shares Outstanding | 24.44M |
| Float | 15.47M |
| Short Ratio | 9.4 |
| % Held by Insiders | 11.60% |
| % Held by Institutions | 64.12% |
| Shares Short | 1.09M |
| Short % of Float | 6.78% |
| Short % of Shares Outstanding | 4.44% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -330.038% |
| Gross Margin | -105.096% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.75% |
| Return on Equity (ttm) | -45.73% |
Income Statement
| Revenue (ttm) | 18.78M USD |
| Revenue Per Share (ttm) | 0.78 USD |
| Quarterly Revenue Growth (yoy) | 154.29% |
| Gross Profit (ttm) | -18781000 USD |
| EBITDA | -61899000 USD |
| Net Income Avi to Common (ttm) | -61879000 USD |
| Diluted EPS (ttm) | -2.6 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 151.17M USD |
| Total Cash Per Share (mrq) | 6.19 USD |
| Total Debt (mrq) | 1.57M USD |
| Total Debt/Equity (mrq) | 1.07 USD |
| Current Ratio (mrq) | 9.293 |
| Book Value Per Share (mrq) | 5.974 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -51535000 USD |
| Levered Free Cash Flow (ttm) | -33142750 USD |
Profile of Aadi Bioscience
| Country | United States |
| State | CA |
| City | Pacific Palisades |
| Address | 17383 Sunset Boulevard |
| ZIP | 90272 |
| Phone | 424 473 8055 |
| Website | https://aadibio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 80 |
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus bound to albumin. The company is also involved in evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Q&A For Aadi Bioscience Stock
What is a current AADI stock price?
Aadi Bioscience AADI stock price today per share is 1.96 USD.
How to purchase Aadi Bioscience stock?
You can buy AADI shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aadi Bioscience?
The stock symbol or ticker of Aadi Bioscience is AADI.
Which industry does the Aadi Bioscience company belong to?
The Aadi Bioscience industry is Biotechnology.
How many shares does Aadi Bioscience have in circulation?
The max supply of Aadi Bioscience shares is 24.55M.
What is Aadi Bioscience Price to Earnings Ratio (PE Ratio)?
Aadi Bioscience PE Ratio is now.
What was Aadi Bioscience earnings per share over the trailing 12 months (TTM)?
Aadi Bioscience EPS is -2.44 USD over the trailing 12 months.
Which sector does the Aadi Bioscience company belong to?
The Aadi Bioscience sector is Healthcare.
Aadi Bioscience AADI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}